Kerry Group plc

Kerry Group plc

KRYAF
Kerry Group plcUS flagOther OTC
81.42
USD
-4.27
- -
13.01BMarket Cap
Kerry Group plc
KRYAF
(Other OTC)

Recent

price

81.42

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
28.3
30.21
33.3
33.22
32.75
34.71
34.83
36.33
37.39
40.96
39.28
41.48
49.45
39.32
40.05
41.07
Revenue per Share
1.85
2.06
1.48
0.48
2.73
2.99
3.03
3.34
3.06
3.2
3.13
4.31
3.42
4.1
4.25
4
Basic EPS, GAAP
1.51
1.43
1.71
1.55
1.16
2.69
2.63
2.13
1.96
2.54
2.22
2.01
2.82
4.26
3.95
3
Free Cash Flow per Basic Share
0.26
0.3
0.33
0.37
0.42
0.47
0.52
0.58
0.65
0.73
0.81
0.89
0.98
1.08
1.19
1.31
Dividend per Share
7.57
8.78
9.7
9.91
11.02
14.19
15.87
19.21
21.75
24.22
26.19
30.09
32.46
34.76
25.44
35.28
Book Value per Share
-2.12
-2.56
-2.54
-2.42
-2.24
-3.94
-1.99
-0.42
-0.35
-0.16
-0.18
0.12
2.84
4.36
4.1
3.1
Tangible Book Value per Share
175
176
176
176
176
176
176
176
177
177
177
177
177
177
173
165
Basic Weighted Avg Shares
4,960
5,302
5,848
5,837
5,757
6,105
6,131
6,408
6,608
7,241
6,953
7,351
8,772
6,975
6,929
6,758
Sales/Revenue/Turnover
9.8
8.89
9.32
9.88
10.66
11.5
11.19
10.98
11.44
11.52
10.37
10.64
10.38
11.78
12.91
13.24
Operating Margin (%)
148
120
138
137
132
163
176
134
188
256
271
282
304
299
323
309
Depreciation Expense
324
361
261
84
480
525
533
588
540
566
554
763
606
728
734
658
Net Income, GAAP
17.46
16.77
17.37
30.76
13.62
12.84
12.86
4.04
12.53
12.29
12.78
6.53
13.23
11.35
13.49
13.17
Effective Tax Rate (%)
6.54
6.8
4.46
1.45
8.34
8.61
8.7
9.18
8.18
7.82
7.97
10.38
6.91
10.44
10.6
9.74
Profit Margin (%)
53
367
128
282
193
352
547
464
621
658
898
1,464
1,280
1,325
1,128
1,117
Working Capital
1,123
1,560
1,287
1,282
1,271
2,012
1,867
1,728
2,120
2,430
2,560
3,164
2,475
2,475
2,538
2,560
LT Debt
1,627
1,845
2,014
1,968
2,236
2,790
3,094
3,573
4,034
4,562
4,656
5,601
6,224
6,523
6,487
5,954
Total Equity
14.2
12.18
12.8
11.55
14.58
13.72
11.58
12.46
11.12
10.67
8.56
8.99
8.55
7.75
7.99
8.24
Return on Invested Capital (%)
14.73
13.85
9.87
4.19
15.98
14.47
12.68
13.06
10.8
9.94
8.73
10.54
7.67
9
9.77
9
Return on Capital (%)
26.99
25.16
16.07
4.9
26.09
23.71
20.16
19.04
14.95
13.94
12.43
15.31
10.94
12.21
13.9
12.9
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.19%
5.49%
-8.23%
Free Cash Flow
3.33%
9.01%
-27.68%
Net Income, GAAP
3.41%
5.56%
-10.33%
Sales/Revenue/Turnover
1.51%
0.28%
-2.48%
Total Cash Common Dividend
10.18%
8.52%
4.87%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
6,975
2024
- -
- -
- -
- -
6,929
2025
- -
- -
- -
- -
6,758

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
4.1
2024
- -
- -
- -
- -
4.25
2025
- -
- -
- -
- -
4

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1.08
2024
- -
- -
- -
- -
1.19
2025
- -
- -
- -
- -
1.31
Business
Kerry Group plc (KRYAF) is a global leader in the development and manufacture of taste and nutrition solutions for the food, beverage, and pharmaceutical industries. The company provides a comprehensive portfolio of products and services, including taste modulation systems, functional ingredients such as emulsifiers, stabilizers, and texturants; nutrition solutions encompassing probiotics, proteins, and enzymes; and customized flavor profiles for categories like savory, sweet, beverages, and dairy. Kerry offers end-to-end services from research and development, application development, and technical support to supply chain optimization, serving multinational food and beverage manufacturers, quick-service restaurants, and pharmaceutical firms worldwide. Headquartered in Tralee, Ireland, and founded in 1972, Kerry Group operates over 150 manufacturing facilities across more than 30 countries in Europe, the Americas, Asia Pacific, and the Middle East, with a strong emphasis on sustainable sourcing and innovation-driven growth in high-growth markets like plant-based and health-focused products. In the last two years, Kerry has pursued strategic expansions including the acquisition of Biosearch Life in 2024 to bolster its natural ingredients and bioscience offerings; a major partnership with an industry-leading plant-based protein innovator announced in early 2025 to accelerate alternative protein solutions; and the launch of the Kerry Health and Nutrition Institute's expanded digital platform for personalized nutrition insights. The company also completed a significant funding round for its sustainability initiatives and reorganized its business segments into streamlined Taste and Nutrition divisions to enhance operational efficiency amid rising demand for clean-label products.

Company News

APIChat
  • Kerry Group plc (KRYAY) Presents at Consumer Analyst Group of New York Conference 2026 Prepared Remarks Transcript

  • Kerry Group plc (KRYAY) Q4 2025 Earnings Call Transcript

  • Kerry Group: Slowly Getting Attractive Again

  • Artisan Value Fund Q3 2025 Top Contributors And Detractors

  • Kerry Group plc (KRYAY) Q3 2025 Earnings Call Transcript

  • Kerry Group: Streamlining The Business After Selling The Dairy Division

  • Kerry Group: Gaining Momentum In Health And Wellness

  • Should You Bring The Luck Of The Irish To Your Investmets?

  • Kerry Group: Expect A Big EPS Increase By 2026